Connection

Elizabeth Garrett-Mayer to Paclitaxel

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Paclitaxel.
Elizabeth Garrett-Mayer
Connection Strength
0.052
Paclitaxel
  1. Cisplatin/Irinotecan versus carboplatin/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer. Am J Clin Oncol. 2010 Aug; 33(4):346-52.
    View in: PubMed
    Score: 0.020
  2. Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. Laryngoscope. 2010 Feb; 120(2):236-42.
    View in: PubMed
    Score: 0.020
  3. A phase I toxicity and feasibility trial of sequential dose-dense induction chemotherapy with doxorubicin, paclitaxel, and 5-fluorouracil followed by high dose consolidation for high-risk primary breast cancer. Breast Cancer Res Treat. 2002 Nov; 76(2):145-56.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.